schaltungsanordnung with two mutually antivalente signals leading ausgaengenThe logic level amplifier circuit, which produces negligible switching noise on the supply line and negligible reflected noise between outputs and input, has two mutually inverse outputs. The circuit comprises an input transistor...
Vacuna antineumocócica conjugada heptavalente en un caso de meningitis recurrente por neumococoa) To establish the possible differences between three different models of PEF-meter, including PF-Control for the first time; b) to build a normogram for each of the three models, as a function ...
M. CampinsElsevier EspañaVacunasVacuna Antineumococica Conjugada 13 Valente. The Natio- nal Network for Immunization Information. Disponible en: http://www.immunizationinfo.org/node/19503.Campins M. Vacuna antineumococica conjugada 13-valente. Vacunas. 2014;15 Supl 1:102-7....
Efecto de la vacuna antineumocócica conjugada 10-valente en el área sur de Santiago de Chile, 2009-2015doi:10.26633/rpsp.2018.155CHILECOMMUNITY-acquired pneumoniaHOSPITAL laboratoriesHOSPITAL recordsBACTERIOLOGYPNEUMOCOCCAL vaccinesObjective. The objective of this study was to evalu...
Insulin glargin in Kombination mit oralen Antidiabetika – Eine kostenquivalente Alternative zu konventioneller Insulintherapie bei Patienten mit Typ-2-DiabetesInsulin glargineType 2 diabetes mellitusOral antidiabetic drugsPharmacoeconomyTreatment costs...
Flores Pérez, P.Sánchez–Bayle, M.ESRevista De Patología RespiratoriaVillalobos Pinto E, Perez Perez A, Cano Fernandez J, et al. Derrame pleural en pacientes hospitalizados en la era de la vacuna antineumococica heptavalente. Revista de Patologia Respiratoria. 2012 (en prensa)....
Seguridad de la vacuna antineumocócica conjugada heptavalente (Prevenar)The pneumococcal conjugate vaccine, newly released in Canada, has been extensively studied and shown to be safe, immunogenic and effective in reducing rates of invasive pneumococcal disease. Before any vaccine is accepted into ...
Cobertura de serotipos de la vacuna antineumococica conjugada heptavalente, Catalun˜ a, 1997-2002. Vacunas 2003;4:73-9.Salleras L, Fenoll A, Domi´nguez A, Navas E, Casal J. Cobertura de serotipos de la vacuna antineumoco´ cica conjugada heptavalente. Catalun˜a, 1997-2002....
. The structure of PsaA has been determined to 2.0 A...doi:10.1016/S1576-9887(00)70219-6Casal, J.Fenoli, A.Elsevier EspañaVacunas Investigación Y Práctica
Plans P: Coste-efectividad de la vacuna antineumocócica 23-valente en Cataluña. Gac Sanit 2002, 16: 392–400.Plans P. Coste-efectividad de la vacunacion antineumococica 23-valente en Cataluna. Gac Sanit 2002;16:392-400.Plans P. 2002. Coste efectividad de la vacunacion antineumoco...